デフォルト表紙
市場調査レポート
商品コード
1395955

ペースメーカー市場:規模、セグメント別、シェア、法規制、償還、手技、2033年までの予測

Pacemakers Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

出版日: | 発行: GlobalData | ページ情報: 英文 | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.70円
ペースメーカー市場:規模、セグメント別、シェア、法規制、償還、手技、2033年までの予測
出版日: 2023年12月21日
発行: GlobalData
ページ情報: 英文
納期: 即納可能 即納可能とは
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

洞結節機能不全としても知られるシックサイナス症候群は、不整脈を引き起こす多くの疾患です。病気性洞症候群の主な原因は、インパルスの発生不全、異常伝導、または洞結節の機能低下です。心ブロックは房室結節またはHis-プルキンエ系の伝導系異常による心房から心室への電気伝導の遮断または遅延です。心ブロックはその重症度によって第1度、第2度、第3度に分類されます。病気性洞症候群と心ブロックは抗不整脈薬で治療できますが、より確実な治療法は心臓ペースメーカーの植え込みで、規則正しい心拍の維持に役立ちます。人工ペースメーカーは高齢の患者にもよく耐えられます。心房ペースメーカーは、慢性心房細動を除くすべての患者において、シックサイナス症候群や心臓ブロックの治療に推奨されています。

当レポートは、世界のペースメーカー市場について詳細に考察し、市場における競合情勢、SWOT分析、2033年までの市場予測、COVID-19の影響、地域、国別の動向などを提供しています。

目次

現在上市されているペースメーカーと競合情勢

  • 主要な業界動向の洞察
  • ペースメーカーのセグメント別総市場収益と2015年~2033年の市場展望
  • セグメント別の手技総数、台数、平均販売価格、市場価値に関する詳細データ

世界、地域、国別の洞察

  • ペースメーカー市場のSWOT分析
  • ペースメーカー市場に関する競合力学の洞察と動向
  • 国別の医療制度の概要
  • 国別の償還政策
  • 国別の医療技術に関する規制の状況
図表

List of Tables

Not Applicable

List of Figures

Not Applicable

目次

Abstract

Pacemakers Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Pacemakers market for the year 2020 and beyond. Sick sinus syndrome also known sinus node dysfunction is a number of conditions causing arrhythmias. The major causes of sick sinus syndrome can be the failure of impulse generation, abnormal conduction or sinus node degradation. Heart block is an interruption or delay of electrical conduction from the atria to the ventricles due to conduction system abnormalities in the AV node or the His-Purkinje system. Heart block is classified into first degree, second degree and third degree heart block based on its severity. Sick sinus syndrome and heart block can be treated with antiarrhythmic medicines but a more reliable treatment is implantation of a cardiac pacemaker which helps in maintaining a regular heartbeat. Artificial pacemakers are well tolerated in elderly patients. Atrial based pacemakers are recommended for treatment of sick sinus syndrome and heart block in all the patients except those with chronic atrial fibrillation.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Pacemakers market and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Pacemakers market revenue by segment and market outlooks from 2015-2033.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Pacemakers market.
  • Competitive dynamics insights and trends provided Pacemakers market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Medtronic Plc, Biotronik SE & Co KG, Abbott Laboratories, Boston Scientific Corp, MicroPort Scientific Corp, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Pacemakers marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Understand the impact of COVID-19 on Pacemakers market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Pacemakers market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Pacemakers market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Pacemakers market from 2015-2033.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable